BARCLAYS PLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTXTQ and the CUSIP is 71426V306. A total of 33 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$29,00069,772
+120196.6%
0.00%
Q3 2018$0580.0%0.00%
Q2 2018$058
-4.9%
0.00%
Q1 2018$061
+5.2%
0.00%
Q4 2017$0580.0%0.00%
Q3 2017$0580.0%0.00%
Q2 2017$0580.0%0.00%
Q1 2017$0580.0%0.00%
Q4 2016$0580.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q2 2017
NameSharesValueWeighting ↓
MARSHALL FINANCIAL GROUP INC /ADV 63,940$27,0000.03%
Aisling Capital LLC 210,000$88,0000.02%
Cetera Investment Advisers 46,750$20,0000.00%
Ruggie Capital Group 12,500$5,0000.00%
AE Wealth Management LLC 14,500$6,0000.00%
Renaissance Technologies 1,145,996$481,0000.00%
Virtu Financial LLC 22,891$10,0000.00%
Simplicity Solutions, LLC 14,500$6,0000.00%
UBS Group AG 8,513$4,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 7$00.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders